Comparação entre os critérios prognósticos de Glasgow e os índices fisiológicos O-POSSUM / P-POSSUM em pacientes com adenocarcinoma gástrico submetidos à gastrectomia e a ocorrência de complicações no pós-operatório precoce
Comparison between Glasgow prognostic criteria and O-POSSUM/ P-POSSUM physiological indices in patients undergoing gastrectomy for gastric adenocarcinoma and the occurrency of early postoperative complications
William Frederic de Araújo Willmer; Edgar Freita Ndunduma Samonge; Oswaldo Esteves Barcia Júnior; Gustavo Magalhães Bogossian; Lia Roque Assumpção; Ruy Garcia Marques
Resumo
Introdução: O câncer gástrico segue como terceira causa de mortalidade mundial por neoplasias malignas. Seus índices prognósticos ainda não foram bem definidos para intervenção cirúrgica quanto à estratificação da intensidade da inflamação crônica. Os Critérios Prognósticos de Glasgow (CPG) e os índices de O-POSSUM e PPOSSUM podem constituir essas padronizações e foram testados para avaliar a associação entre eles e o prognóstico após gastrectomia curativa.
Método: Estudo retrospectivo, analisando prontuários de pacientes com adenocarcinoma gástrico e submetidos à gastrectomia, no período de 2015 até 2021, em dois hospitais no Rio de Janeiro. Foram observados a extensão cirúrgica, os dados clínicos e laboratoriais pré, peri e pós-operatórios, até 30 dias após a cirurgia. Os pacientes foram estratificados pelos CPG e comparados segundo classificação de ClavienDindo (CD). Regressão logística foi realizada para testar associação entre o desfecho e variáveis independentes.
Resultados: Dos 48 doentes, 56,25% eram do sexo feminino. Houve diferença entre os grupos quanto à extensão cirúrgica e CPG (ambos com p<0,001), enquanto O-POSSUM, P-POSSUM e idade não apresentaram diferença. Fatores associados com complicação CD ≥ III-a na análise univariada foram CPG (OR: 85,261; IC: 24,909-291,831) e P-POSSUM (OR: 1,211; IC: 1,044-1,404). Na análise multivariada, os fatores independentes associados ao CD ≥ III-a foram CPG (OR: 114,865; IC: 15,430-855,086), P-POSSUM (OR: 1,133; IC: 1,086-1,181) e O-POSSUM (OR: 2,238; IC: 1,790-2,797).
Conclusão: Neste modelo, CPG, P-POSSUM e O-POSSUM previram complicações cirúrgicas graves. Há necessidade de estudos mais aprofundados para instituir estratégias de forma a minimizar a resposta inflamatória no período pré-operatório.
Palavras-chave
Abstract
Introduction: Gastric cancer is still the third cause of death worldwide due to malignant neoplasms. Its prognostic indices have not yet been well defined for surgical intervention in terms of stratifying the intensity of chronic inflammation. The Glasgow Prognostic Score (GPS) and O-POSSUM and P-POSSUM Indices may constitute these standardizations and were tested to assess the association between them and the prognosis after curative gastrectomy.
Method: Retrospective observational study, analysing medical records of patients with gastric adenocarcinoma who underwent gastrectomy, from 2015 to 2021, in two hospitals in Rio de Janeiro. Surgical extension, pre, peri and postoperative clinical and laboratory data were observed, up to 30 days after surgery. Patients were layered by GPS and compared according to the Clavien-Dindo (CD) classification. Logistic regression was performed to test the association between the outcome and independent variables.
Results: Of the 48 patients, 56.25% were female. There was difference between the groups regarding surgical extension and GPS (both with p<0.001), while O-POSSUM, P-POSSUM and age showed no difference. Factors associated with CD ≥ III-a complication in the univariate analysis were GPS (OR: 85,261; CI: 24,909- 291,831) and P-POSSUM (OR: 1,211; CI:1,044-1,404). In the multivariate analysis, the independent factors associated with CD ≥ III-a were GPS (OR:114,865; CI: 15,430-855,086), P-POSSUM (OR: 1,133; CI: 1,086-1,181) and O-POSSUM (OR: 2,238; CI: 1,790-2,797).
Conclusion: In this model, GPS, P-POSSUM and O-POSSUM predicted serious surgical complications. There is a need for further studies to establish strategies to minimize the inflammatory response in the preoperative period.
Keywords
Referências
1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424. doi: 10.3322/caac.21492.
2 Butt J, Varga MG, Wang T, Tsugane S, Shimazu T, Zheng W, et al. Smoking, Helicobacter pylori serology, and gastric cancer risk in prospective studies from China, Japan, and Korea. Cancer Prev Res (Phila). 2019;12(10):667-74. doi: 10.1158/1940-6207.CAPR-19-0238.
3 Kumar S, Metz DC, Ellenberg S, Kaplan DE, Goldberg DS. Risk factors and incidence of gastric cancer after detection of Helicobacter pylori infection: a large cohort study. Gastroenterology. 2020;158(3):527-36. doi: 10.1053/j.gastro.2019.10.019.
4 Li Y, Eshak ES, Shirai K, Liu K, Dong J, Iso H, et al. Alcohol consumption and risk of gastric cancer: the Japan collaborative cohort study. J Epidemiol. 2021;31(1):30-6. doi: 10.2188/jea.JE20190304.
5 Liabeuf D, Oshima M, Stange DE, Sigal M. Stem cells, Helicobacter pylori, and mutational landscape: utility of preclinical models to understand carcinogenesis and to direct management of gastric cancer. Gastroenterology. 2022;162(4):1067-87. doi: 10.1053/j.gastro.2021.12.252.
6 Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635-48. doi: 10.1016/S0140-6736(20)31288-5.
7 Israel DA, Peek RM. Pathogenesis of Helicobacter pylori-induced gastric inflammation. Aliment Pharmacol Ther. 2001;15(9):1271-90. doi: 10.1046/j.1365-2036.2001.01052.x.
8 Ma J, Yao S, Li XS, Kang HR, Yao FF, Du N. Neoadjuvant therapy of DOF regimen plus bevacizumab can increase surgical resection ratein locally advanced gastric cancer: a randomized, controlled study. Medicine (Baltimore). 2015;94(42):e1489. doi: 10.1097/MD.0000000000001489.
9 Bernardo AT, Eloi T, Amaral LA, Quintanilha R, Melo AS. Avaliação da performance cirúrgica pelo P-POSSUM em doentes com cancro gástrico: revisão de 5 anos. Rev Port Cir. 2016;(36):9-18.
10 Forrest LM, McMillan DC, McArdle CS, Angerson WJ, Dunlop DJ. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer. 2003;89(6):1028-30. doi: 10.1038/sj.bjc.6601242.
11 Kubota T, Hiki N, Sano T, Nomura S, Nunobe S, Kumagai K, et al. Prognostic significance of complications after curative surgery for gastric cancer. Ann Surg Oncol. 2014;21(3):891-8. doi: 10.1245/s10434-013-3384-9.
12 McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534-40. doi: 10.1016/j.ctrv.2012.08.003.
13 Horzic M, Kopljar M, Cupurdija K, Bielen DV, Vergles D, Lackovic Z. Comparison of P-POSSUM and Cr-POSSUM scores in patients undergoing colorectal cancer resection. Arch Surg. 2007;142(11):1043-8. doi: 10.1001/archsurg.142.11.1043.
14 Kubota T, Hiki N, Nunobe S, Kumagai K, Aikou S, Watanabe R, et al. Significance of the inflammation-based Glasgow prognostic score for short- and longterm outcomes after curative resection of gastric cancer. J Gastrointest Surg. 2012;16(11):2037-44. doi: 10.1007/s11605-012-2036-x.
15 Figueiredo HF, Da Rosa RD, Fujimoto LBM, Pereira RMA, Westphal FL, Nakajima GS. Desempenho do escore prognóstico de Glasgow no câncer gástrico. Medicina. 2021;54(4):e-174590. doi: 10.11606/issn.21767262.rmrp.2021.174590.
16 Poziomyck AK, Cavazzola LT, Coelho LJ, Lameu EB, Weston AC, Moreira LF. Nutritional assessment methods as predictors of postoperative mortality in gastric cancer patients submitted to gastrectomy. Rev Col Bras Cir. 2017;44(5):482-90. doi: 10.1590/0100-69912017005010.
17 Mortensen K, Nilsson M, Slim K, Schäfer M, Mariette C, Braga M, et al. Consensus guidelines for enhanced recovery after gastrectomy. Brit J Surg. 2014;101(10):1209-29. doi: 10.1002/bjs.9582.
18 Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R. Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc. 2013;27(5):1509-20. doi: 10.1007/s00464-012-2661-1.
19 Etoh T, Honda M, Kumamaru H, Miyata H, Yoshida K, Kodera Y, et al. Morbidity and mortality from a propensity score-matched, prospective cohort study of laparoscopic versus open total gastrectomy for gastric cancer: data from a nationwide web-based database. Surg Endosc. 2018;32(6):2766-73. doi: 10.1007/s00464-017-5976-0.
20 Shen J, Feng X, Li Z, Wang Y. Comparison of short-term outcomes between robotic and laparoscopic distal gastrectomy performed by the same surgical team during the same period. Front Oncol. 2023;13:1174396. doi: 10.3389/fonc.2023.1174396.
21 Guerrini GP, Esposito G, Magistri P, Serra V, Guidetti C, Olivieri T, et al. Robotic versus laparoscopic gastrectomy for gastric cancer: the largest metaanalysis. Int J Surg. 2020;82:210-28. doi: 10.1016/j.ijsu.2020.07.053.
22 Zizzo M, Zanelli M, Sanguedolce F, Torricelli F, Morini A, Tumiati D, et al. Robotic versus laparoscopic gastrectomy for gastric cancer: an updated systematic review. Medicina (Kaunas). 2022;58(6):834. doi: 10.3390/medicina58060834.
23 Ishizuka M, Oyama Y, Abe A, Tago K, Tanaka G, Kubota K. Clinical significance of an inflammation-based prognostic system for gastric cancer patients with a preoperative normal serum level of carcinoembryonic antigen. Anticancer Res. 2014;34(12):7219-26.
24 Carvalho-E-Carvalho ME, De-Queiroz FL, Martins-Da-Costa BX, WerneckCôrtes MG, Pires-Rodrigues V. Aplicação dos escores POSSUM e P-POSSUM como preditores de morbimortalidade em cirurgia colorretal. Rev Col Bras Cir. 2018;45(1):e1347. doi: 10.1590/0100-6991e-20181347.
25 Mukherjee S, Kedia A, Goswami J, Chakraborty A. Validity of P-POSSUM in adult cancer surgery (PACS). J Anaesthesiol Clin Pharmacol. 2022;38(1):61-5. doi: 10.4103/joacp.JOACP_128_20.
26 Dutta S, Al-Mrabt NM, Fullarton GM, Horgan PG, McMillan DC. A comparison of POSSUM and GPS models in the prediction of post-operative outcome in patients undergoing oesophago-gastric cancer resection. Ann Surg Oncol. 2011;18(10):2808-17. doi: 10.1245/s10434-011-1676-5.
27 Dutta S, Horgan PG, McMillan DC. POSSUM and its related models as predictors of postoperative mortality and morbidity in patients undergoing surgery for gastro-oesophageal cancer: a systematic review. World J Surg. 2010;34(9):2076-82. doi: 10.1007/s00268-010-0685-z.
28 Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies. Int J Mol Sci. 2020;21(11):4012. doi: 10.3390/ijms21114012.
29 Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, et al. Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94(22):1680-7. doi: 10.1093/jnci/94.22.1680.
30 Toh JWT, Wilson RB. Pathways of gastric carcinogenesis, Helicobacter pylori virulence and interactions with antioxidant systems, vitamin c and phytochemicals. Int J Mol Sci. 2020;21(17):6451. doi: 10.3390/ijms21176451.
31 Leung WK, Sung JJ. Review article: intestinal metaplasia and gastric carcinogenesis. Aliment Pharmacol Ther. 2002;16(7):1209-16. doi: 10.1046/j.13652036.2002.01300. x.
32 Jin Y, Zhao L, Peng F. Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer. Clinics (São Paulo). 2013;68(5):686-93. doi: 10.6061/clinics/2013(05)17.
33 Leedham SJ, Schier S, Thliveris AT, Halberg RB, Newton MA, Wright NA. From gene mutations to tumours: stem cells in gastrointestinal carcinogenesis. Cell Prolif. 2005;38(6):387-405. doi: 10.1111/j.1365-2184.2005.00359. x.
34 Hurwitz EE, Simon M, Vinta SR, Zehm CF, Shabot SM, Minhajuddin A, et al. Adding examples to the ASA-Physical Status Classification improves correct assignment to patients. Anesthesiology. 2017;126(4):614-22. doi: 10.1097/ALN.0000000000001541.
Submetido em:
03/10/2023
Aceito em:
12/02/2024
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email